Trial · NCT04292912
Outcomes27
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
21 to 27 of 27
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| SECONDARY | Plasma Concentrations of GSK2798745 | Day 7 (Pre-dose, 0.5 hour [h], 1h, 2h, 3h, 4h, 6h, 8h) and Day 28 (Pre-dose, 0.5h, 1h, 2h, 3h, 4h, 6h, 8h) | The pharmacokinetic population included all participants from the modified safety population who received at least one dose of study treatment for whom PK sample was obtained and analyzed. Only those participants with evaluable PK data at the specified time points were used for analysis. Overall number of participants analyzed=number of participants contributed to the analysis. | nanograms per milliliter | GEOMETRIC_MEAN |
| SECONDARY | Plasma Concentrations of Major Metabolite M1 | Day 7 (Pre-dose, 0.5h, 1h, 2h, 3h, 4h, 6h, 8h) and Day 28 (Pre-dose, 0.5h, 1h, 2h, 3h, 4h, 6h, 8h) | The pharmacokinetic population included all participants from the modified safety population who received at least one dose of study treatment for whom PK sample was obtained and analyzed. Only those participants with evaluable PK data at the specified time points were used for analysis. Overall number of participants analyzed=number of participants contributed to the analysis. | nanograms per milliliter | GEOMETRIC_MEAN |
| SECONDARY | Absorption Rate of GSK2798745 | Day 28 | The intensive PK analysis population included all participants from the modified Safety population who had intensive PK sampling on Day 7 and Day 28. However, since only one participant consented to intensive PK and this participant withdrew early, before Day 28, data for this endpoint were not collected. | ||
| SECONDARY | Clearance of GSK2798745 | At Day 28 | The intensive PK analysis population included all participants from the modified Safety population who had intensive PK sampling on Day 7 and Day 28. However, since only one participant consented to intensive PK and this participant withdrew early, before Day 28, data for this endpoint were not collected. | ||
| SECONDARY | Volume of Distribution of GSK2798745 | At Day 28 | The intensive PK analysis population included all participants from the modified Safety population who had intensive PK sampling on Day 7 and Day 28. However, since only one participant consented to intensive PK and this participant withdrew early, before Day 28, data for this endpoint were not collected. | ||
| SECONDARY | Maximum Observed Plasma Concentration (Cmax) of GSK2798745 | At Day 28 | The intensive PK analysis population included all participants from the modified Safety population who had intensive PK sampling on Day 7 and Day 28. However, since only one participant consented to intensive PK and this participant withdrew early, before Day 28, data for this endpoint were not collected. | ||
| SECONDARY | Area Under Concentration-Time Curve (AUC) Over Dosing Interval of GSK2798745 | At Day 28 | The intensive PK analysis population included all participants from the modified Safety population who had intensive PK sampling on Day 7 and Day 28. However, since only one participant consented to intensive PK and this participant withdrew early, before Day 28, data for this endpoint were not collected. |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04292912/outcomes?page=2